Approval · Notice of Compliance 22739 · 2019
VENTIPULMIN: Notice of Compliance 22739
Issued October 2, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22739
- Date
- October 2, 2019
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VENTIPULMIN | 00705845 | Marketed |
Medicinal ingredients
- CLENBUTEROL HCL 0.025 MG per ML